• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYZZ2500011 香松通络油 Liniment Chinese Herbal Medicine License Renew 2025-06-12 Ling Nam Medicine Factory(HK)Ltd view
JYZZ2500010 香松通络油 Liniment Chinese Herbal Medicine License Renew 2025-06-12 Ling Nam Medicine Factory(HK)Ltd view
JYSZ2500017 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500016 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500015 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2500014 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSB2500131 乙型肝炎病毒 丙型肝炎病毒 人类免疫缺陷病毒(1+2型)核酸检测试剂盒(PCR-荧光法) Diagnostic reagent IVD Supplementary Application 2025-06-12 Roche Molecular Systems Inc view
JYSB2500130 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2025-06-05 Cilag AG;Janssen-Cilag International NV view
JYSB2500129 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2025-06-04 Janssen Biologics BV;Cilag AG view
JYSB2500128 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2025-06-04 Ipsen Ltd;Ipsen Biopharm Ltd view
JYHZ2500115 苯磺酸氨氯地平片 amlodipine besylate Tablet Chemical Drugs License Renew 2025-06-12 Novartis Pharmaceutical Manufacturing LLC;Lek Pharmaceuticals DD view
JYHZ2500114 盐酸厄洛替尼片 erlotinib hydrochloride Tablet Chemical Drugs License Renew 2025-06-05 CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl;Beijing Anlongtai Science and Technology Co Ltd view
JYHZ2500113 盐酸厄洛替尼片 erlotinib hydrochloride Tablet Chemical Drugs License Renew 2025-06-05 CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl;Beijing Anlongtai Science and Technology Co Ltd view
JYHZ2500112 牛磺熊去氧胆酸胶囊 tauroursodeoxycholic acid Capsule Chemical Drugs License Renew 2025-06-05 Bruschettini Srl;Beijing Trendful Kangjian Medical Information Consulting Co Ltd;Doppel Farmaceutical Srl view
JYHB2500316 玛巴洛沙韦片 baloxavir marboxil Tablet Chemical Drugs(5.1) Supplementary Application 2025-06-12 Shionogi Pharma Co Ltd;Roche Pharma (Schweiz) AG view
JYHB2500315 玛巴洛沙韦片 baloxavir marboxil Tablet Chemical Drugs(5.1) Supplementary Application 2025-06-12 Roche Pharma (Schweiz) AG view
JYHB2500314 复方肝素钠尿囊素凝胶 Gel Chemical Drugs Supplementary Application 2025-06-12 Merz Pharmaceuticals GmbH;Merz Pharma Gmbh & Co KGaA view
JYHB2500313 复方肝素钠尿囊素凝胶 Gel Chemical Drugs Supplementary Application 2025-06-12 Merz Pharmaceuticals GmbH;Merz Pharma Gmbh & Co KGaA view
JYHB2500312 普拉替尼胶囊 pralsetinib Capsule Chemical Drugs(1) Supplementary Application 2025-06-12 Catalent Cts LLC;Rigel Pharmaceuticals Inc view
JYHB2500311 布地奈德福莫特罗吸入气雾剂(I) Budesonide;Formoterol Inhalation Chemical Drugs(5.2) Supplementary Application 2025-06-10 Kindeva Drug Delivery;Mylan Pharmaceuticals Inc view